In the News
powered by Ovast-
Mixed Messages On Rare Disease Drug
abcnews.com 2 days, 1 hour agoAn FDA advisory panel said a study of Vyndaqel for familial amyloid polyneuropathy did not provide proof of its benefit, but that proof may not be necessary.
-
What Is Life? Follow The Bits
msnbc.com 2 weeks, 4 days agoScience editor Alan Boyle's blog: A pioneer on the frontier of biochemistry proposes a method to tell whether scientists are actually looking at a new form of life: Follow the bits.


Loading More Stories